Clinical Research Support
The Clinical Trial begins with a pharmacy consultant. At MAPRx, we support you with the following:
|
|
Active Clinical Trials MAPRx collaborates.
NOTICE: MAPRx does not perform any recruitment.
Stanford University
The BIomarker Guided Study for Depression (BIG)
COVID-19 Outpatient Pragmatic Platform Study (COPPS): Acebilustat
Efficacy of Medical Therapy in Women and Men with Angina and Myocardial Bridging
COVID-19 Outpatient Pragmatic Platform Study (COPPS): Acebilustat
A Phase 2 Randomized, Double Blinded, Placebo Controlled Study of Oral Camostat Mesilate Compared to Standard Supportive Care in Subjects with Mild or Asymptomatic COVID-19
Oral Favipiravir Compared to Placebo in Subjects With Mild COVID-19
Low-dose naltrexone for Bladder Pain Syndrome.
Single-Blind Study of a Single Dose of Peginterferon Lambda-1a Compared With Placebo in Outpatients With Mild COVID-19 (COVID-Lambda)
Intranasal Vasopressin Treatment in Children With Autism
A Study of Esomeprazole in Children With Autism
A Study of N-Acetyl Cysteine in Children With Autism
The Effects of Tranexamic Acid on Joint Inflammation and Cartilage Health in Anterior Cruciate Ligament Injured Patients
Opiate Suicide Study in Patients With Major Depression (AFSP)
Ketamine in OCD NMDAR Modulation as a Therapeutic Target & Probe of Neural Dysfunction in OCD
Sickness Evaluation at Altitude With Acetazolamide at Relative Dosages (SEAWARD)
The BIomarker Guided Study for Depression (BIG)
JAK Inhibition to Prevent Ventilator-induced Diaphragm Dysfunction
Efficacy of Medical Therapy in Women and Men With Angina and Myocardial Bridging
Postoperative Pain Management in Rhinoplasty
The Role of Secondary Bile Acids in Intestinal Inflammation
COVID-19 Outpatient Pragmatic Platform Study (COPPS): Acebilustat
Efficacy of Medical Therapy in Women and Men with Angina and Myocardial Bridging
COVID-19 Outpatient Pragmatic Platform Study (COPPS): Acebilustat
A Phase 2 Randomized, Double Blinded, Placebo Controlled Study of Oral Camostat Mesilate Compared to Standard Supportive Care in Subjects with Mild or Asymptomatic COVID-19
Oral Favipiravir Compared to Placebo in Subjects With Mild COVID-19
Low-dose naltrexone for Bladder Pain Syndrome.
Single-Blind Study of a Single Dose of Peginterferon Lambda-1a Compared With Placebo in Outpatients With Mild COVID-19 (COVID-Lambda)
Intranasal Vasopressin Treatment in Children With Autism
A Study of Esomeprazole in Children With Autism
A Study of N-Acetyl Cysteine in Children With Autism
The Effects of Tranexamic Acid on Joint Inflammation and Cartilage Health in Anterior Cruciate Ligament Injured Patients
Opiate Suicide Study in Patients With Major Depression (AFSP)
Ketamine in OCD NMDAR Modulation as a Therapeutic Target & Probe of Neural Dysfunction in OCD
Sickness Evaluation at Altitude With Acetazolamide at Relative Dosages (SEAWARD)
The BIomarker Guided Study for Depression (BIG)
JAK Inhibition to Prevent Ventilator-induced Diaphragm Dysfunction
Efficacy of Medical Therapy in Women and Men With Angina and Myocardial Bridging
Postoperative Pain Management in Rhinoplasty
The Role of Secondary Bile Acids in Intestinal Inflammation
UCSF
Effects of Sleeve Gastrectomy on Calcium Metabolism and the Skeleton
Metformin for Pulmonary Hypertension HFpEF (PH-HFpEF)
MOntelukast as a Potential CHondroprotective Treatment Following Anterior Cruciate Ligament Reconstruction (MOCHA Trial) (MOCHA)
Letrozole in Patients With Hepatopulmonary Syndrome
The Effect of NAC on Lung Function and CT Mucus Score (ENACT)
Metformin for Pulmonary Hypertension HFpEF (PH-HFpEF)
MOntelukast as a Potential CHondroprotective Treatment Following Anterior Cruciate Ligament Reconstruction (MOCHA Trial) (MOCHA)
Letrozole in Patients With Hepatopulmonary Syndrome
The Effect of NAC on Lung Function and CT Mucus Score (ENACT)
UC Berkeley
Aging Mitochondrial Fragmentation and Metabolic Inflexibility
